Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001037389-25-000069
Filing Date
2025-11-13
Accepted
2025-11-13 14:27:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7495
  Complete submission text file 0001037389-25-000069.txt   9556
Mailing Address 800 THIRD AVE NEW YORK NY 10022
Business Address 800 THIRD AVE NEW YORK NY 10022 (212) 872-1646
RENAISSANCE TECHNOLOGIES LLC (Filed by) CIK: 0001037389 (see all company filings)

EIN.: 260385758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Subject) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89966 | Film No.: 251477388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)